Gen Digital Inc. engages in the provision of cyber safety solutions for consumers in the United States, Canada, Latin America, Europe, the Middle East, Africa, the Asia Pacific, and Japan. The company offers security and performance products under Norton, Avast, Avira, AVG, and CCleaner brands that provide real-time protection and maintenance for PCs, Macs, and mobile devices against malware, viruses, adware, and other online threats. It also provides identity protection solutions, including LifeLock Identity Theft Protection, Avast and AVG Secure Identity, Norton Identity Theft Protection, and Dark Web Monitoring for monitoring of credit reports, financial accounts, the dark web, and social media accounts to help safeguard customers' personal information. In addition, the company offers Virtual Private Network (VPN) solutions under Norton, Avast and AVG brands to enhance security and online privacy that allows customers to securely transmit and access private information, such as passwords, bank details, and credit card numbers, when using public Wi-Fi on PCs, Macs, and mobile iOS and Android devices; AntiTrack and Secure Browser products which helps to keep personal information and browsing activity anonymous while browsing online; and Privacy Monitor Assistant and BreachGuard products for removing customers' data from public data broker sites; and ReputationDefender, a white glove service that helps customers manage all aspects of their personal branding online, including search results, social media sites, and overall web presence. It markets and sells its products and related services through retailers, telecom service providers, hardware original equipment manufacturers, and employee benefit providers, as well as e-commerce platform. The company was formerly known as NortonLifeLock Inc. and changed its name to Gen Digital Inc. in November 2022. Gen Digital Inc. was founded in 1982 and is headquartered in Tempe, Arizona.

Gen Digital Inc.

Barclays analyst Larissa Van Deventer maintained a Buy rating on Legal & General today and set a price target of £3.40. According to TipRanks, Van ...

Barclays Sticks to Their Buy Rating for Legal & General (LGEN)

RBC Capital analyst Mandeep Jagpal maintained a Sell rating on Legal & General yesterday and set a price target of p205.00. According to TipRanks, ...

RBC Capital Reaffirms Their Sell Rating on Legal & General (LGEN)

An announcement from Qiagen ( ($QGEN) ) is now available. QIAGEN has reported that the Dutch financial markets regulator AFM notified the company o...

Goldman Sachs Discloses 3.26% Voting Interest in QIAGEN

Legal & General ( ($GB:LGEN) ) has provided an announcement. Legal & General Group Plc has disclosed share purchases by three non-executive directo...

Legal & General Non-Executive Directors Increase Shareholdings Under Appointment Terms

Legal & General ( ($GB:LGEN) ) has provided an update. Legal & General Group Plc has reported that, as of 30 January 2026, its issued share capital...

Legal & General Confirms Total Voting Rights and Share Capital Structure

The latest announcement is out from Legal & General ( ($GB:LGEN) ). Legal & General Group has completed the sale of its US insurance entity, which ...

Legal & General Sells US Insurance Arm to Meiji Yasuda and Launches £1.2bn Buyback

There’s a lot to be optimistic about in the Communication Services sector as 2 analysts just weighed in on Spotify (SPOT – Research Report) and Gen...

Analysts Are Bullish on Top Communication Services Stocks: Spotify (SPOT), Genius Sports Limited (GENI)

Analysts have been eager to weigh in on the Communication Services sector with new ratings on AppLovin (APP – Research Report) and Genius Sports Li...

Analysts Offer Insights on Communication Services Companies: AppLovin (APP) and Genius Sports Limited (GENI)

The latest update is out from Qiagen ( ($QGEN) ). Qiagen announced that the Dutch Authority for the Financial Markets (AFM) has disclosed a notific...

Barclays Discloses 3.26% Voting Stake in Qiagen

Qiagen ( ($QGEN) ) has provided an update. QIAGEN disclosed that the Dutch financial regulator AFM has published a voting rights notification showi...

Goldman Sachs discloses 2.93% voting interest in QIAGEN

Qiagen ( ($QGEN) ) has issued an update. Qiagen disclosed that the Dutch financial markets regulator AFM has notified the company of a substantial ...

Qiagen Reports Goldman Sachs Builds 3.15% Voting Stake via Shares and Derivatives

The latest announcement is out from Qiagen ( ($QGEN) ). QIAGEN has disclosed that the Dutch financial markets regulator AFM notified the company of...

DWS Investment Reports 3.02% Voting Stake in QIAGEN

Qiagen ( ($QGEN) ) just unveiled an announcement. Qiagen has disclosed a voting rights announcement following notification from the Dutch financial...

DWS Investment Reports Significant Voting Stake in Qiagen

Genuit Group ( ($GB:GEN) ) has shared an announcement. Genuit Group has confirmed its current share capital structure, stating that as of 30 Januar...

Genuit Group Confirms Total Voting Rights and Share Capital

Genmin Ltd. ( ($AU:GEN) ) has shared an announcement. Genmin Limited has strengthened its balance sheet and advanced funding plans for its flagship...

Genmin Secures Funding Boost and Chinese Partner Support as Baniaka Nears Key Milestones

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Repligen (RGEN – Research Report) and Definium Thera...

Analysts Are Bullish on These Healthcare Stocks: Repligen (RGEN), Definium Therapeutics (DFTX)

The latest update is out from Qiagen ( ($QGEN) ). QIAGEN has disclosed a managers’ transaction under market abuse regulations involving supervisory...

QIAGEN Reports Equity Vesting for Departing Supervisory Board Member

In a report released today, Larissa Van Deventer from Barclays maintained a Buy rating on Legal & General, with a price target of £3.40. According ...

Barclays Reaffirms Their Buy Rating on Legal & General (LGEN)

GENinCode UK Ltd. ( ($GB:GENI) ) has issued an announcement. GENinCode Plc has completed its WRAP Retail Offer, launched on 21 January 2026, raisin...

GENinCode Raises £4.1m Following Completion of WRAP Retail Offer

In a report released on January 23, Harry Gillis from Berenberg Bank maintained a Buy rating on Qiagen, with a price target of €46.00. The company’...

Berenberg Bank Keeps Their Buy Rating on Qiagen (QGEN)

An update from Qiagen ( ($QGEN) ) is now available. Qiagen disclosed that the Dutch Financial Markets Authority (AFM) has published a substantial s...

Qiagen Reports AFM Notification of DWS Investment’s 2.98% Voting Stake

Qiagen ( ($QGEN) ) has issued an announcement. QIAGEN N.V. reported that the Dutch financial regulator AFM has notified the company of a substantia...

DWS Investment Discloses 3.06% Voting Stake in QIAGEN

Qiagen ( ($QGEN) ) has issued an announcement. QIAGEN N.V. has published a notification of voting rights after the Dutch financial markets regulato...

Goldman Sachs Discloses 2.92% Voting Interest in QIAGEN

Delta Cleantech ( ($TSE:RGEN) ) has provided an update. Regenera Insights Inc. has announced the resignation of director Steve Olasz and the appoin...

Regenera Refreshes Board with Appointment of Independent Director Douglas Whitehead

Genus plc ( ($GB:GNS) ) has issued an announcement. Genus plc has secured regulatory approval in Canada for the use of its gene-edited PRRS Resista...

Genus Wins Canadian Approval for Gene-Edited PRRS-Resistant Pig

Northland Securities analyst Greg Gibas maintained a Buy rating on Genius Sports Limited yesterday and set a price target of $15.00. According to T...

Northland Securities Sticks to Their Buy Rating for Genius Sports Limited (GENI)

Gencor ( ($GENC) ) has provided an announcement. Gencor Industries has scheduled its Annual Meeting of Stockholders for the fiscal year ended Septe...

Gencor Sets 2026 Annual Meeting and Governance Deadlines

GENinCode UK Ltd. ( ($GB:GENI) ) has shared an announcement. GENinCode plc has conditionally raised £3.9 million before expenses through a heavily ...

GENinCode Raises £3.9m via Discounted Placing and Director-Backed Subscription

An update from GENinCode UK Ltd. ( ($GB:GENI) ) is now available. GENinCode Plc has launched a retail share offer via the Winterflood Retail Access...

GENinCode Opens WRAP Retail Offer Alongside £3.5m Placing at Deep Discount

The latest update is out from GENinCode UK Ltd. ( ($GB:GENI) ). GENinCode plc has announced a conditional equity fundraising of at least £3.5 milli...

GENinCode Launches Discounted £3.5m Fundraise to Back US and European Expansion

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Argenx Se (ARGX – Research Report), Agenus (AGEN – R...

Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX), Agenus (AGEN) and Assertio Therapeutics (ASRT)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on NRX Pharmaceuticals (NRXP – Research Report) and Qiagen (QGEN – R...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: NRX Pharmaceuticals (NRXP) and Qiagen (QGEN)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Qiagen (QGEN – Research Report) and Merck & Company (MRK – Resear...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Qiagen (QGEN) and Merck & Company (MRK)

Analysts fell to the sidelines weighing in on Atlassian (TEAM – Research Report) and Gen Digital (GEN – Research Report) with neutral ratings, indi...

Analysts’ Top Technology Picks: Atlassian (TEAM), Gen Digital (GEN)

In a report released on January 16, from Deutsche Bank reiterated a Buy rating on Genus plc, with a price target of p3,300.00. The company’s shares...

Deutsche Bank  Remains a Buy on Genus plc (GNS)

Shore Capital analyst reiterated a Buy rating on Genus plc today and set a price target of p3,000.00. In a report released today, Berenberg Bank al...

Shore Capital Sticks to Its Buy Rating for Genus plc (GNS)

In a report released today, Robert Chantry from Berenberg Bank reiterated a Buy rating on Genus plc, with a price target of p3,250.00. Chantry cove...

Berenberg Bank Remains a Buy on Genus plc (GNS)

An announcement from Agenus ( ($AGEN) ) is now available. On January 15, 2026, Agenus closed a $141 million strategic collaboration with Zydus Life...

Agenus Forms Major Strategic Collaboration with Zydus Lifesciences

Qiagen ( ($QGEN) ) has provided an update. Qiagen has disclosed a voting rights announcement following notification from the Dutch regulator AFM th...

Goldman Sachs Discloses 3.6% Voting Stake in Qiagen

The latest announcement is out from Qiagen ( ($QGEN) ). Qiagen N.V. has disclosed that the Dutch financial markets regulator AFM notified the compa...

Qiagen Reports AFM Notification of Major Stake by Massachusetts Financial Services

Qiagen ( ($QGEN) ) has shared an update. Qiagen has disclosed a notification from the Dutch Authority for the Financial Markets indicating that Mas...

Massachusetts Financial Services Discloses Nearly 10% Voting Stake in Qiagen

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Disc Medicine (IRON – Research Report) and Agenus (A...

Analysts’ Top Healthcare Picks: Disc Medicine (IRON), Agenus (AGEN)

The latest announcement is out from Generation Gold Corp. Class A ( ($TSE:GEN) ). Generation Uranium Inc. has signed a definitive agreement to acqu...

Generation Uranium Expands Nunavut Footprint With Yath Extension Acquisition

There’s a lot to be optimistic about in the Communication Services sector as 2 analysts just weighed in on Alphabet Class A (GOOGL – Research Repor...

Analysts Offer Insights on Communication Services Companies: Alphabet Class A (GOOGL) and Genius Sports Limited (GENI)

In a report released today, Patrick Scholes from Truist Financial maintained a Buy rating on Genius Sports Limited, with a price target of $10.23. ...

Truist Financial Sticks to Its Buy Rating for Genius Sports Limited (GENI)

The latest announcement is out from Qiagen ( ($QGEN) ). QIAGEN has disclosed a management transaction involving Thierry Bernard, a member of its ma...

QIAGEN Adjusts Management Shareholdings Following Synthetic Share Repurchase

An update from Qiagen ( ($QGEN) ) is now available. QIAGEN has reported a management-related share consolidation involving board member Elizabeth T...

QIAGEN Board Member’s Holdings Adjusted Following Share Consolidation

Qiagen ( ($QGEN) ) has issued an update. QIAGEN N.V. has reported a manager’s transaction involving supervisory board member Toralf Haag, following...

QIAGEN Reports Manager’s Share Consolidation Under Synthetic Buyback Program

Qiagen ( ($QGEN) ) has issued an update. QIAGEN has reported a managers’ transaction involving CC Verwaltungs GmbH, an entity controlled by supervi...

QIAGEN adjusts insider shareholdings after synthetic share repurchase and consolidation

Qiagen ( ($QGEN) ) has provided an announcement. QIAGEN has reported a manager transaction involving supervisory board member Metin Colpan followin...

QIAGEN discloses management share consolidation under synthetic repurchase program

Qiagen ( ($QGEN) ) has issued an update. QIAGEN has disclosed a managers’ transaction involving board member Ross Levine, whose shareholding was af...

QIAGEN Adjusts Board Member Shareholding Following Synthetic Share Consolidation

Qiagen ( ($QGEN) ) has provided an announcement. QIAGEN has disclosed a managerial transaction involving Chief Financial Officer and managing board...

QIAGEN Adjusts CFO’s Shareholdings After Synthetic Share Repurchase and Consolidation

The latest update is out from Qiagen ( ($QGEN) ). QIAGEN N.V. has disclosed a managers’ transaction involving board member Stephen H. Rusckowski fo...

QIAGEN adjusts board member shareholding after synthetic share consolidation

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Repligen (RGEN – Research Report) and NeoGenomics (N...

Wall Street Analysts Are Bullish on Top Healthcare Picks

J.P. Morgan analyst Lushanthan Mahendrarajah reiterated a Buy rating on Genuit Group yesterday. The company’s shares closed today at p328.50. Accor...

J.P. Morgan Remains a Buy on Genuit Group (GEN)

Generation Mining ( ($TSE:GENM) ) has provided an announcement. Generation Mining has upsized its previously announced bought‑deal private placemen...

Generation Mining Upsizes Bought‑Deal Financing to C$30 Million for Marathon Project

Generation Mining ( ($TSE:GENM) ) has issued an update. Generation Mining has launched a $20 million bought deal public offering, selling 27.78 mil...

Generation Mining Launches $20 Million Bought Deal to Advance Marathon Project

The latest announcement is out from Legal & General ( ($GB:LGEN) ). Legal & General has disclosed that Laura Mason, CEO of Retail and a person disc...

Legal & General Retail CEO Exercises Performance Share Awards and Retains Shares

FibroGen ( ($FGEN) ) just unveiled an update. On December 29, 2025, FibroGen filed a certificate of amendment in Delaware to change its corporate n...

FibroGen rebrands as Kyntra Bio, refocuses on oncology

Foresight Environmental Infrastructure Limited GBP ( ($GB:FGEN) ) has issued an update. Foresight Environmental Infrastructure is navigating a chal...

Foresight Environmental Infrastructure Holds Course Amid UK Policy Shake-Up

In a report released today, Larissa Van Deventer from Barclays maintained a Buy rating on Legal & General, with a price target of £3.40. Van Devent...

Barclays Sticks to Its Buy Rating for Legal & General (LGEN)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Day One Biopharmaceuticals (DAWN – Research Report),...

Analysts Offer Insights on Healthcare Companies: Day One Biopharmaceuticals (DAWN), Tenet Healthcare (THC) and Repligen (RGEN)

Repligen ( ($RGEN) ) has provided an update. On January 6, 2026, Repligen Corporation announced that its board has elected independent director Dr....

Repligen Appoints Martin Madaus as New Board Chair

Legal & General ( ($GB:LGEN) ) just unveiled an update. Legal & General Group Plc has disclosed that several senior executives, including the Group...

Legal & General Executives Acquire Shares Under Employee Plan

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Simulations Plus (SLP – Research Report), Qiagen (...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	GEN	$23.79	-0.83%	5.86M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	GEN	$23.79	-0.8%	5.86M
3
4
5
6

GEN

GEN

Get Gen Digital Inc. Data in Excel

Get Gen Digital Inc. Data in Excel